Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer
AMBUPRO
Pilot Feasibility Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer
1 other identifier
interventional
20
1 country
1
Brief Summary
The promoter propose a pilot study evaluating the feasability of robot-assisted radical prostatectomy on outpatient in patients with localized prostate cancer. This study will enrole a total of 20 patients over one center, followed for 1 month. The total study duration will be 15 months, including statistical analysis and publication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable prostate-cancer
Started Jan 2022
Typical duration for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2020
CompletedFirst Posted
Study publicly available on registry
March 24, 2020
CompletedStudy Start
First participant enrolled
January 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedDecember 4, 2025
November 1, 2025
3.9 years
March 17, 2020
November 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Absence of conventional hospitalization after robot-assisted radical prostatectomy
24 hours following the intervention
Secondary Outcomes (7)
Outpatient failure defined by a Chung score of less than 9 who cannot be discharged or admitted to a conventional hospitalization.
24 hours following the intervention
Mesure of the operation duration will be estimated in minutes and will be recorded with a stopwatch in the operating room
The day of surgery
The complication rate is determined by the number of patients who had one or more complications in the first month following the operation. Complications will be graded according to the Clavien Dindo classification.
within the month after surgery
The consultation rate in a doctor's office is set by the number of patients who consulted a general practitioner in the first month after the operation, declared by the patient during the control visite (at 1 month)
one month after surgery
•Any form of admission for urological reasons judged by the investigator in relation to robot-assisted radical prostatectomy within one month after the operation is considered as early unscheduled re-hospitalisation.
one month after surgery
- +2 more secondary outcomes
Study Arms (1)
robot-assisted radical prostatectomy
OTHERpatient with a prostate cancer will be operated with a robot-assisted method. They will be supported on an outpatient basis
Interventions
robot-assisted radical prostatectomy as first-line treatment
Eligibility Criteria
You may qualify if:
- Men
- Older than 18 years old, if\> 70 years old, then patient having had a favorable onco-geriatric consultation (Balducci 2 and life expectancy\> 10 years)
- Patient with localized prostate cancer applying for radical prostatectomy treatment
- Patient accepting outpatient surgery
- Radical prostatectomy performed as first-line treatment
- BMI \<35
- ASA score \<3
- Accompanying person available (taxi authorized) to ensure return home
- Have quick access to a telephone line
- Patient who signed their informed consent
- Patient covered by social security or other health insurance
You may not qualify if:
- History of major abdominal surgery
- History of pelvic radiotherapy
- History of major urogenital malformation
- Sleep apnea syndrome
- Taking the following drugs within 48 hours (Plavix®, anti-vitamin K / curative LMWH)
- Contraindication to ambulatory medical care
- Inability to understand and sign the informed consent and to complete the self-questionnaires
- Vulnerable people
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de NICE Pasteur 2
Nice, CHU de Nice, 06000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2020
First Posted
March 24, 2020
Study Start
January 25, 2022
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
December 4, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
no plan description is necessary